Details of the Drug
General Information of Drug (ID: DMW8IN3)
Drug Name |
4-(4-FLUOROBENZYL)PIPERIDINE
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-(4'-Fluorobenzyl)piperidine; 92822-02-1; 4-[(4-fluorophenyl)methyl]piperidine; 4-(4-fluorobenzyl)piperidine; 4-(4-fluoro-benzyl)-piperidine; PIPERIDINE, 4-[(4-FLUOROPHENYL)METHYL]-; CHEMBL144527; piperidine 4; PubChem12570; AC1Q4MDN; chembrdg-bb 4010301; AC1MWI24; SCHEMBL895063; 4-(4-fluorobenzyl)-piperidine; 4-(4'-fluorobenzyl) piperidine; CTK8F5377; BDBM15788; DTXSID30395219; JLAKCHGEEBPDQI-UHFFFAOYSA-N; MolPort-002-053-743; HMS3604B15; 4-(4-flourophenylmethyl)piperidine; ZINC2512916; ALBB-014951; KS-00002B8F
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 193.26 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||